M. Richardson

A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study

Sally J Singh, M. Orme, D. Esliger, 2022, Respiratory Research.

Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.

M. Richardson, S. Adams, L. Siegel, 2001, MMWR. Morbidity and mortality weekly report.

Reducing the number and impact of outbreaks of nosocomial viral gastroenteritis: time-series analysis of a multidimensional quality improvement initiative

Gary B. Smith, P. Meredith, M. Richardson, 2015, BMJ Quality & Safety.

Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study

L. Wain, W. Man, C. Brightling, 2021, medRxiv.

A data-driven framework for clinical decision support applied to pneumonia management

R. Free, G. Woltmann, P. Haldar, 2023, medRxiv.

Inflammation profiling and recovery clusters five months post-hospitalisation for COVID-19

M. Richardson, R. Saunders, M. Marks, 2022, 01.01 - Clinical problems - no related to asthma or COPD.

Predicting Future Health Risk in COPD: Differential Impact of Disease-Specific and Multi-Morbidity-Based Risk Stratification

Sally J. Singh, M. Steiner, J. Quint, 2021 .